Sign up to save your podcasts
Or
Share AI Access Brief Podcast
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
AI Access Brief Podcast
AI Access Brief Podcast episodes
- US Market Access ShiftsEpisode 71 — 27 July 2026Examining US healthcare access pressures, new Alzheimer's treatment formulations, insulin pricing enforcement, and evolving evidence strategies.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast8 min
- Profit Warning, Approval, Settlement, ExpansionEpisode 70 — 26 July 2026Examining HCA's profit warning impact on US healthcare access, SubQ Leqembi approval HEOR implications, FTC insulin pricing settlement, and ICER scientific advice expansion.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast8 min
- HCA Profit Warning & SubQ LeqembiEpisode 69 — 25 July 2026Examining HCA's profit warning signaling U.S. healthcare access pressures, subcutaneous Leqembi's HEOR implications, FTC's insulin pricing settlement, and ICER's expanded scientific advice program.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast10 min
- Profit Warnings & Pricing ScrutinyEpisode 68 — 24 July 2026Hospital profit warnings and regulatory settlements signal systemic US healthcare access challenges, while new drug approvals and evidence frameworks evolve rapidly.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast8 min
- US Access & Evidence ShiftsEpisode 67 — 23 July 2026Examining US healthcare system pressures, novel drug evidence challenges, insulin pricing enforcement, and Medicaid policy shifts shaping market access strategies.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast10 min
- EMA RWE Pediatric Pilot & CMS Rebate ShiftEpisode 66 — 22 July 2026EMA launches pediatric RWE pilot for rare diseases; ISPOR 2026 highlights PRO framework shifts; CMS proposes Medicaid rebate changes; HTAI-IQVIA launches global RWE database.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast9 min
- Profit Warnings, Insulin Settlements, and LeqembiEpisode 65 — 21 July 2026Hospital system financial pressures, insulin pricing settlements, new Alzheimer's formulation approvals, and evolving HTA evidence strategies.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast10 min
- HTA Evidence EvolutionEpisode 64 — 20 July 2026Examining RWE adoption challenges, digital therapeutics value assessment, orphan drug evidence standards, and AI's role in HTA methodologies.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast10 min
- HTA Methodology Shifts & Pricing PressuresEpisode 63 — 19 July 2026Examining evolving HTA methodologies, CMS coverage shifts, patent settlement impacts, and NICE's equity framework.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast7 min
- HTA Methodology Shifts & FDA Accelerated ApprovalsEpisode 62 — 18 July 2026Examining evolving HTA frameworks in Asia-Pacific, Canada's pricing reforms, RWE integration barriers in Latin America, and gene therapy evidence strategies in Asia.Hosted by Marcus and Sara.Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.Full transcript and sources at outcomes-analytica.no/podcast9 min
About AI Access Brief Podcast
From the publisher's feed
AI Generated Daily briefings on HEOR, HTA strategy and the evidence access landscape. For pharmaceutical and biotech professionals navigating regulatory-payer alignment, HTA submissions, and…
evidence strategy.